EEB-20039-62848
4 vaccinations
8 coded responses
31 check-ins
8 free-text entries
5 call cases
- Sex
- Female
- Age at first dose
- 41-45
- ZIP prefix
- 372 / TN
- Registered
- 2020-12-30
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-30
Registered in v-safe
-
2020-12-30
Dose 1 — Pfizer-BioNTech
-
2020-12-30
Survey response — day 0, dose 1MedDRA: Flushing, Hypertension — Feeling: Good · Site: Redness · HeadacheFree text: Flushing of face, high blood pressureMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2020-12-31
-
2021-01-01
Health check-in — days 1–6 daily, dose 1Feeling: Good · Headache, Fatigue or tirednessAdult check-in
- 2021-01-03
- 2021-01-04
- 2021-01-06
- 2021-01-06
-
2021-01-15
Survey response — day 14, dose 1MedDRA: Adrenal insufficiency, Asthenia, Balance disorder, Decreased appetite, Dizziness, Fall, Fatigue, Tunnel vision — Feeling: Fair · Be unable to workFree text: Adrenal insufficiency episode with no known infection or illness. Dizziness, tunnel vision, fall on ground, loss of balance, no appetite, weakness and severe fatigueMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-01-15
- 2021-01-20
-
2021-01-21
Dose 2 — Pfizer-BioNTech
-
2021-02-10
Survey response — day 14, dose 2MedDRA: Diarrhoea — Feeling: GoodFree text: Diarrhea is worseMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-02-11
- 2021-02-18
- 2021-02-25
- 2021-03-04
-
2021-04-23
Survey response — 3 months, dose 2MedDRA: Dyspnoea — Feeling: Good · Be unable to do your normal daily activitiesFree text: Worsening difficulty breathingMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-07-23
-
2021-09-10
Dose 3 — Pfizer-BioNTech
- 2021-09-29
- 2021-10-02
-
2021-10-08
Survey response — day 28, dose 3MedDRA: Anxiety, Pre-existing disease — Feeling: Fair · Be unable to work or attend schoolFree text: Worsening anxietyMedDRA releases: 2024-11 · check-in free text available
- 2021-10-17
- 2021-10-22
- 2021-12-10
-
2022-02-12
Dose 4 — Pfizer-BioNTech
- 2022-02-12
- 2022-02-13
-
2022-02-14
Health check-in — days 1–6 daily, dose 4Feeling: Fair · Site: Pain, Swelling · Fatigue or tirednessAdult check-in
- 2022-02-26
- 2022-03-08
- 2022-03-13
- 2022-03-21
-
2022-03-26
Survey response — day 42, dose 4MedDRA: Raynaud's phenomenon — Feeling: Good · Get care from a doctor or other healthcare professional · Emergency room or emergency department visitFree text: Raynaud's phenomenonMedDRA releases: 2024-11 · check-in free text available
-
2022-03-26
Report sent to call center — day 42, dose 4Get care from a doctor or other healthcare professionalEmergency room or emergency department visit · 1 call case(s)
- 2022-03-28
-
2022-03-31
Call successfulCompleted over the phone
-
2022-05-15
Survey response — 3 months, dose 4MedDRA: Erythema, Flushing, Peripheral swelling, Raynaud's phenomenon — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit, Emergency room or emergency department visitFree text: Hands are red and swollen most of time, Raynaud phenomenon (new after booster) is worse, areas of arms and upper arms are red and stay flushedMedDRA releases: 2024-11 · check-in free text available
-
2022-05-15
Report sent to call center — 3 months, dose 4Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prOutpatient clinic or urgent care clinic visit · Emergency room or emergency department visit · 1 call case(s)
- 2022-05-16
-
2022-08-13
Survey response — 6 months, dose 4MedDRA: Erythromelalgia — Feeling: Fair · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: ErythromelalgiaMedDRA releases: 2024-11 · check-in free text available
-
2022-08-13
Report sent to call center — 6 months, dose 4Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
- 2022-08-15
- 2022-08-15
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-30 | Pfizer-BioNTech | |
| 2 | 2021-01-21 | Pfizer-BioNTech | |
| 3 | 2021-09-10 | Pfizer-BioNTech | No |
| 4 | 2022-02-12 | Pfizer-BioNTech | No |
Call center
5 call center cases
1 successful · 2 unsuccessful · 2 priority 2/3 (triaged and no follow up)
VAERS report filed, before or during a call: 1
Free text
Release 1 — day 0, dose 1
Systemic reaction (other): Flushing of face, high blood pressure
Release 2 — day 14, dose 1
Symptoms: Adrenal insufficiency episode with no known infection or illness. Dizziness, tunnel vision, fall on ground, loss of balance, no appetite, weakness and severe fatigue
Release 4 — day 14, dose 2
Symptoms: Diarrhea is worse
Release 7 — 3 months, dose 2
Symptoms: Worsening difficulty breathing
Release 10 — day 28, dose 3
Symptoms: Worsening anxiety
Release 11 — day 42, dose 4
Symptoms: Raynaud's phenomenon
Release 11 — 3 months, dose 4
Symptoms: Hands are red and swollen most of time, Raynaud phenomenon (new after booster) is worse, areas of arms and upper arms are red and stay flushed
Release 12 — 6 months, dose 4
Symptoms: Erythromelalgia
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Adrenal insufficiency | ✓ | ✓ | ✓ |
| SD | Anxiety | · | · | ✓ |
| SD | Asthenia | ✓ | ✓ | ✓ |
| SD | Balance disorder | ✓ | ✓ | ✓ |
| SD | Decreased appetite | ✓ | ✓ | ✓ |
| SD | Diarrhoea | ✓ | ✓ | ✓ |
| SD | Dizziness | ✓ | ✓ | ✓ |
| SD | Dyspnoea | ✓ | ✓ | ✓ |
| SD | Erythema | · | · | ✓ |
| SD | Erythromelalgia | · | · | ✓ |
| SD | Fall | ✓ | ✓ | ✓ |
| SD | Fatigue | ✓ | ✓ | ✓ |
| SD | Flushing | · | · | ✓ |
| SD | Peripheral swelling | · | · | ✓ |
| SD | Pre-existing disease | · | · | ✓ |
| SD | Raynaud's phenomenon | · | · | ✓ |
| SD | Tunnel vision | ✓ | ✓ | ✓ |
| SRO | Flushing | ✓ | ✓ | ✓ |
| SRO | Hypertension | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release